Alfred J. Ford Jr

Insider Reports History

Location
3303 Monte Villa Parkway, Bothell, WA
Signature
/s/ Alfred J. Ford, Jr.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alfred J. Ford Jr:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KESTRA MEDICAL TECHNOLOGIES, LTD. Chief Commercial Officer Options 118K $2.78M $23.58 Jul 17, 2025 Direct
KESTRA MEDICAL TECHNOLOGIES, LTD. Chief Commercial Officer Common Shares 29.4K $694K $23.58 Jul 17, 2025 Direct
Axonics, Inc. Chief Commercial Officer Common Stock 0 $0 $71.00 Nov 15, 2024 Direct
Axonics, Inc. Chief Commercial Officer Performance-Based Restricted Stock Units 0 $0 $71.00 Nov 15, 2024 Direct
Axonics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 0 $0 $45.18 Nov 15, 2024 Direct

Insider Reports Filed by Alfred J. Ford Jr

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. Jul 17, 2025 1 $0 4 Jul 21, 2025 Chief Commercial Officer
KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. Mar 7, 2025 1 $340K 4/A Sep 15, 2025 Chief Commercial Officer
KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. Mar 6, 2025 0 $0 3 Mar 6, 2025 Chief Commercial Officer
AXNX Axonics, Inc. Nov 15, 2024 3 -$3.3M 4 Nov 15, 2024 Chief Commercial Officer
AXNX Axonics, Inc. Jan 31, 2024 4 -$1.13M 4 Feb 2, 2024 Chief Commercial Officer
AXNX Axonics, Inc. Aug 15, 2023 1 -$921K 4 Aug 17, 2023 Chief Commercial Officer
AXNX Axonics, Inc. Jul 28, 2023 1 -$93K 4 Aug 1, 2023 Chief Commercial Officer
AXNX Axonics, Inc. Jan 31, 2023 10 -$607K 4 Feb 2, 2023 Chief Commercial Officer
AXNX Axonics, Inc. Jan 13, 2023 11 -$1.9M 4 Jan 18, 2023 Chief Commercial Officer
AXNX Axonics, Inc. Jan 31, 2022 8 -$447K 4 Feb 3, 2022 Chief Commercial Officer